PMEL and melanoma: Tebentafusp is an ImmTAC molecule that targets a fragment of the melanocytes lineage-specific antigen gp100280–288 (alternative names Melanocyte protein Pmel17, melanoma-associated ME20 antigen, ME20-M, [UniProtKB-P40967]) presented by HLA-A*02:01 [87].